# Sanofi vs Stryker: valuation, size and margins compared

URL: https://funkfolio.com/compare/sny-vs-syk

> Sanofi ($114.1B, P/E 23.6) and Stryker ($120.9B, P/E 33.8) compared: size, valuation, margins, debt, cash and price change.

---

## Sanofi vs Stryker

Sanofi (SNY), health care, and Stryker (SYK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Stryker is worth $120.9B on the stock market and Sanofi $114.1B: Stryker is valued at 6% more. Sanofi trades at 23.6 times earnings and Stryker at 33.8; operating margins in their latest fiscal years were 14.5% and 19.5%. Over the past year Sanofi's share price has moved -4.48% and Stryker's -13.6%.

### Key facts

- **Sanofi market value:** $114.1B
- **Stryker market value:** $120.9B
- **Sanofi P/E:** 23.6
- **Stryker P/E:** 33.8
- **Sanofi revenue:** $48.4B FY to 2025-12-31
- **Stryker revenue:** $25.1B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 09:39 UTC.

Sanofi vs Stryker: every measure side by side

| Measure | Sanofi | Stryker |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | France | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $114.1B lower | $120.9B higher |
| Revenue | $48.4B higher | $25.1B lower |
| Earnings | $8.7B higher | $3.2B lower |
| Employees | 74,846 higher | 56,000 lower |
| Total assets | $140.7B higher | $47.8B lower |
| Valuation |  |  |
| P/E | 23.6 lower | 33.8 higher |
| P/S | 2.4 lower | 4.8 higher |
| P/B | — | 5.2 |
| Dividend yield | — | 1.13% |
| Profitability |  |  |
| Operating margin | 14.5% lower | 19.5% higher |
| Balance sheet |  |  |
| Net assets | $79.2B higher | $22.4B lower |
| Total liabilities | $61.1B higher | $25.4B lower |
| Total debt | $20.8B higher | $15.9B lower |
| Cash on hand | $8.5B higher | $4B lower |
| Price change |  |  |
| Today | -1.78% lower | +2.19% higher |
| 1 year | -4.48% higher | -13.6% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Sanofi 91.8, Stryker 88.2.

- Sanofi (SNY)
- Stryker (SYK)

Sanofi and Stryker share prices over one year, rebased to 100: Sanofi ends at 91.8, Stryker at 88.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | SNY | SYK |
| --- | --- | --- |
| Nov 28, 2025 | 96.3 | 103.1 |
| Dec 31, 2025 | 93.6 | 97.6 |
| Jan 30, 2026 | 90.8 | 102.6 |
| Feb 27, 2026 | 94.0 | 107.6 |
| Mar 31, 2026 | 93.0 | 91.2 |
| Apr 30, 2026 | 90.0 | 87.5 |
| May 29, 2026 | 84.3 | 84.7 |
| Jun 30, 2026 | 82.4 | 87.4 |
| Jul 31, 2026 | 83.2 | 90.4 |
| Aug 31, 2026 | 85.7 | 89.9 |
| Sep 30, 2026 | 79.6 | 76.5 |
| Oct 30, 2026 | 85.6 | 81.0 |
| Nov 17, 2026 | 91.8 | 88.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### Sanofi only (7)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.2%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.5%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.4%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.1%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) &lt;0.1%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) &lt;0.1%

#### Stryker only (8)

- [Terry Smith](https://funkfolio.com/gurus/terry-smith) 5.7%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) 3.1%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 1.5%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.8%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 0.7%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio. [Who owns SNY](https://funkfolio.com/stock/SNY/superinvestors) · [Who owns SYK](https://funkfolio.com/stock/SYK/superinvestors)

### More on Sanofi

- [Sanofi (SNY) stock page](https://funkfolio.com/stock/SNY)
- [Sanofi market cap](https://funkfolio.com/stock/SNY/market-cap)
- [Sanofi revenue](https://funkfolio.com/stock/SNY/revenue)
- [Sanofi P/E ratio](https://funkfolio.com/stock/SNY/pe-ratio)
- [Sanofi operating margin](https://funkfolio.com/stock/SNY/operating-margin)
- [Sanofi total debt](https://funkfolio.com/stock/SNY/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Stryker

- [Stryker (SYK) stock page](https://funkfolio.com/stock/SYK)
- [Stryker market cap](https://funkfolio.com/stock/SYK/market-cap)
- [Stryker revenue](https://funkfolio.com/stock/SYK/revenue)
- [Stryker P/E ratio](https://funkfolio.com/stock/SYK/pe-ratio)
- [Stryker operating margin](https://funkfolio.com/stock/SYK/operating-margin)
- [Stryker total debt](https://funkfolio.com/stock/SYK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Sanofi against its closest peers

- [Sanofi vs Moderna](https://funkfolio.com/compare/mrna-vs-sny)
- [Sanofi vs McKesson](https://funkfolio.com/compare/mck-vs-sny)
- [Sanofi vs CVS Health](https://funkfolio.com/compare/cvs-vs-sny)

#### Stryker against its closest peers

- [Stryker vs McKesson](https://funkfolio.com/compare/mck-vs-syk)
- [Stryker vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-syk)
- [Stryker vs Medtronic](https://funkfolio.com/compare/mdt-vs-syk)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Sanofi or Stryker?**

By market value, Stryker is the larger: $120.9B against $114.1B for Sanofi. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $25.1B for Stryker.

**Which has the higher P/E ratio?**

Stryker: 33.8, against 23.6 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Stryker: 19.5%, against 14.5% for Sanofi. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Sanofi: $20.8B, against $15.9B for Stryker. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Sanofi and Stryker?**

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Sanofi and 8 hold Stryker.

### Cite this page

Funkfolio, “Sanofi vs Stryker”, data as of 18 November 2026. https://funkfolio.com/compare/sny-vs-syk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
